Search

everythinglearnresearchcommunity

for

Search:↓

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Hair follicles help skin immune recovery after UVB exposure.

Herbal remedies might help with hair loss but need more research for safety and effectiveness.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Microorganism overgrowth and hyperkeratosis may trigger immune reactions causing lichen planopilaris.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Chemicals and stem cells combined have advanced regenerative medicine with few safety concerns, focusing on improving techniques and treatment effectiveness.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.